US authorizes new antibody drug to fight omicron
Oncology dietitians rarely ask cancer patients about food insecurity, study finds
11 February 2022China gives conditional approval for Pfizer COVID pill: drug regulator
12 February 2022US authorizes new antibody drug to fight omicron
U.S. health regulators on Friday authorized a new antibody drug that targets the omicron variant, a key step in restocking the nation’s arsenal against the latest version of COVID-19.
